Abbott Rapid Dx North America LLC Point-of-Care Analyzer Kit Binaxnow® 22 Tests CLIA Waived

Abbott Rapid Dx North America LLC Point-of-Care Analyzer Kit Binaxnow 22 Tests CLIA Waived - M-1087252-4489 | Each

$6,842.99
Packaging *

Abbott Rapid Dx North America LLC

Point-of-Care Analyzer Kit

In Stock

M-1087252-4489

-
+
$6,842.99
secure_pay

Delivery - 7-10 Days, Ship Directly from Manufacturer

  • Alere BinaxNOW® Influenza A & B Card 2 is an in vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal (NP) swab and nasal swab samples
  • Alere BinaxNOW® Influenza A & B Card 2 must be read by the Alere™ Reader
  • The first rapid antigen influenza test to achieve 510(k) clearance as a Class II assay under the new FDA Reclassification performance requirements

    • Item Id 1087252
    MF ID LFR124
    Brand Binaxnow®
    Manufacturer Abbott Rapid Dx North America LLC
    Application Point-of-Care Analyzer Kit
    CLIA Classification CLIA Waived
    Contents1 Alere™ Reader, Barcode Scanner, Alere Binaxnow® Tray Pack, Calibration Check Card Pack, Alere™ USB Drive
    Dimensions 125 X 160 X 195 mm
    For Use With For Alere™ Reader
    Number of Tests 22 Tests
    Power Source 100 to 240 VAC, 50/60 Hz
    Readout Type Touch Screen, Printout
    Sample Type Nasal Swab / Nasopharyngeal Swab
    Test Name Influenza A + B Test
    Time To Results 15 Minute Results
    UNSPSC Code 41115808
    User Interface 4-1/3 Inch Touch Screen
    Weight 3.3 lbs

    Recently Viewed Products

    FDA Disclaimer: "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."